Status:
RECRUITING
OSA in Never Smokers With Lung Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Lung Cancer
Obstructive Sleep Apnea
Eligibility:
All Genders
19-80 years
Brief Summary
Previous studies have yielded inconsistent findings regarding the association between obstructive sleep apnea and the prevalence and mortality of lung cancer. Smoking history, a common risk factor for...
Eligibility Criteria
Inclusion
- \- Never smokers who are admitted to the Seoul National University Hospital and newly diagnosed with lung cancer, with ECOG Performance Status 0 or 1
Exclusion
- Patients who have received treatment for lung cancer before the enrollment
- Patients who have received treatment for OSA before the enrollment
- Patients with an expected life expectancy of less than 3 months
- Patients with neuromuscular disease, chronic opioid medication use, or severe insomnia not controlled by medication
- Patients receiving supplemental oxygen therapy due to underlying diseases including heart failure, chronic obstructive pulmonary disease, interstitial pulmonary disease, hypoventilation syndrome, stroke, or whose baseline oxygen saturation is less than 90%
- Patients with unstable medical conditions within the preceding 3 months (hospitalization due to acute exacerbation of underlying lung disease, diagnosis of unstable angina or myocardial infarction, history of percutaneous coronary intervention or coronary artery bypass surgery, or diagnosis of transient ischemic attack or stroke)
- Patients with an inability or unwillingness to provide informed consent
Key Trial Info
Start Date :
November 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05224180
Start Date
November 3 2021
End Date
December 31 2028
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080